
### [NCIT:C34433](http://purl.obolibrary.org/obo/NCIT_C34433)
**Label:** Bone Marrow Disorder

**Subclasses:** [NCIT:C7506](http://purl.obolibrary.org/obo/NCIT_C7506) (Myelodysplastic Syndrome with Excess Blasts), [NCIT:C9129](http://purl.obolibrary.org/obo/NCIT_C9129) (Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia), [NCIT:C9128](http://purl.obolibrary.org/obo/NCIT_C9128) (Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia), [NCIT:C82423](http://purl.obolibrary.org/obo/NCIT_C82423) (Acute Myeloid Leukemia with t(6;9) (p23;q34.1); DEK-NUP214), [NCIT:C125715](http://purl.obolibrary.org/obo/NCIT_C125715) (Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes), [NCIT:C82426](http://purl.obolibrary.org/obo/NCIT_C82426) (Acute Myeloid Leukemia with inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM), [NCIT:C7064](http://purl.obolibrary.org/obo/NCIT_C7064) (Erythroid Neoplasm), [NCIT:C7463](http://purl.obolibrary.org/obo/NCIT_C7463) (Acute Myelomonocytic Leukemia), [NCIT:C122725](http://purl.obolibrary.org/obo/NCIT_C122725) (Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 5q), [NCIT:C82427](http://purl.obolibrary.org/obo/NCIT_C82427) (Acute Myeloid Leukemia (Megakaryoblastic) with t(1;22)(p13.3;q13.3); RBM15-MKL1), [NCIT:C7066](http://purl.obolibrary.org/obo/NCIT_C7066) (Megakaryocytic Neoplasm), [NCIT:C122726](http://purl.obolibrary.org/obo/NCIT_C122726) (Childhood Acute Myeloid Leukemia with Abnormalities of Chromosome 7), [NCIT:C122686](http://purl.obolibrary.org/obo/NCIT_C122686) (Hypocellular Myelodysplastic Syndrome), [NCIT:C122687](http://purl.obolibrary.org/obo/NCIT_C122687) (Cytogenetically Normal Acute Myeloid Leukemia), [NCIT:C122688](http://purl.obolibrary.org/obo/NCIT_C122688) (Core Binding Factor Acute Myeloid Leukemia), [NCIT:C94810](http://purl.obolibrary.org/obo/NCIT_C94810) (Inherited Bone Marrow Failure Syndrome), [NCIT:C134319](http://purl.obolibrary.org/obo/NCIT_C134319) (Refractory Acute Myeloid Leukemia), [NCIT:C2862](http://purl.obolibrary.org/obo/NCIT_C2862) (Primary Myelofibrosis), [NCIT:C9019](http://purl.obolibrary.org/obo/NCIT_C9019) (Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11), [NCIT:C9018](http://purl.obolibrary.org/obo/NCIT_C9018) (Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11), [NCIT:C9020](http://purl.obolibrary.org/obo/NCIT_C9020) (Acute Myelomonocytic Leukemia with Abnormal Eosinophils), [NCIT:C38377](http://purl.obolibrary.org/obo/NCIT_C38377) (Acute Myeloid Leukemia with t(17;17)(q21;q21)), [NCIT:C9381](http://purl.obolibrary.org/obo/NCIT_C9381) (Childhood Acute Myeloid Leukemia with Maturation), [NCIT:C9380](http://purl.obolibrary.org/obo/NCIT_C9380) (Adult Acute Myeloid Leukemia without Maturation), [NCIT:C122690](http://purl.obolibrary.org/obo/NCIT_C122690) (Acute Myeloid Leukemia with t(7;12)(q36;p13); HLXB9-ETV6), [NCIT:C3247](http://purl.obolibrary.org/obo/NCIT_C3247) (Myelodysplastic Syndrome), [NCIT:C7968](http://purl.obolibrary.org/obo/NCIT_C7968) (Childhood Acute Promyelocytic Leukemia with PML-RARA), [NCIT:C7964](http://purl.obolibrary.org/obo/NCIT_C7964) (Adult Acute Basophilic Leukemia), [NCIT:C7600](http://purl.obolibrary.org/obo/NCIT_C7600) (Acute Myeloid Leukemia with Myelodysplasia-Related Changes), [NCIT:C3249](http://purl.obolibrary.org/obo/NCIT_C3249) (Acute Myeloid Leukemia without Maturation), [NCIT:C7965](http://purl.obolibrary.org/obo/NCIT_C7965) (Adult Acute Megakaryoblastic Leukemia), [NCIT:C3248](http://purl.obolibrary.org/obo/NCIT_C3248) (Myelofibrosis), [NCIT:C7168](http://purl.obolibrary.org/obo/NCIT_C7168) (Myelodysplastic Syndrome with Excess Blasts-2), [NCIT:C7167](http://purl.obolibrary.org/obo/NCIT_C7167) (Myelodysplastic Syndrome with Excess Blasts-1), [NCIT:C7962](http://purl.obolibrary.org/obo/NCIT_C7962) (Adult Acute Myelomonocytic Leukemia), [NCIT:C7961](http://purl.obolibrary.org/obo/NCIT_C7961) (Adult Acute Myeloid Leukemia with Maturation), [NCIT:C82403](http://purl.obolibrary.org/obo/NCIT_C82403) (Acute Myeloid Leukemia with t(9;11)(p22.3;q23.3); MLLT3-KMT2A), [NCIT:C9068](http://purl.obolibrary.org/obo/NCIT_C9068) (Recurrent Childhood Acute Myeloid Leukemia), [NCIT:C122625](http://purl.obolibrary.org/obo/NCIT_C122625) (Childhood Acute Myeloid Leukemia Not Otherwise Specified), [NCIT:C8252](http://purl.obolibrary.org/obo/NCIT_C8252) (Therapy-Related Acute Myeloid Leukemia), [NCIT:C7320](http://purl.obolibrary.org/obo/NCIT_C7320) (Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C7171](http://purl.obolibrary.org/obo/NCIT_C7171) (Acute Monoblastic Leukemia), [NCIT:C68698](http://purl.obolibrary.org/obo/NCIT_C68698) (Adult Acute Myeloid Leukemia with t(16;16)(p13.1;q22); CBFB-MYH11), [NCIT:C68699](http://purl.obolibrary.org/obo/NCIT_C68699) (Adult Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1), [NCIT:C68696](http://purl.obolibrary.org/obo/NCIT_C68696) (Adult Acute Myeloid Leukemia with t(9;11)(p22.3;q23.3); MLLT3-KMT2A), [NCIT:C68697](http://purl.obolibrary.org/obo/NCIT_C68697) (Adult Acute Myeloid Leukemia with inv(16)(p13.1q22); CBFB-MYH11), [NCIT:C9070](http://purl.obolibrary.org/obo/NCIT_C9070) (Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C27280](http://purl.obolibrary.org/obo/NCIT_C27280) (Secondary Myelodysplastic Syndrome), [NCIT:C3407](http://purl.obolibrary.org/obo/NCIT_C3407) (Essential Thrombocythemia), [NCIT:C6924](http://purl.obolibrary.org/obo/NCIT_C6924) (Acute Myeloid Leukemia with Variant MLL Translocations), [NCIT:C97310](http://purl.obolibrary.org/obo/NCIT_C97310) (Myelodysplastic Syndrome with Gene Mutation), [NCIT:C4344](http://purl.obolibrary.org/obo/NCIT_C4344) (Acute Panmyelosis with Myelofibrosis), [NCIT:C27780](http://purl.obolibrary.org/obo/NCIT_C27780) (Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable), [NCIT:C4861](http://purl.obolibrary.org/obo/NCIT_C4861) (Acute Monocytic Leukemia), [NCIT:C27262](http://purl.obolibrary.org/obo/NCIT_C27262) (Myelodysplastic/Myeloproliferative Neoplasm), [NCIT:C4345](http://purl.obolibrary.org/obo/NCIT_C4345) (Myeloproliferative Neoplasm), [NCIT:C8304](http://purl.obolibrary.org/obo/NCIT_C8304) (Childhood Acute Myeloid Leukemia with Minimal Differentiation), [NCIT:C3250](http://purl.obolibrary.org/obo/NCIT_C3250) (Acute Myeloid Leukemia with Maturation), [NCIT:C7971](http://purl.obolibrary.org/obo/NCIT_C7971) (Childhood Acute Basophilic Leukemia), [NCIT:C4582](http://purl.obolibrary.org/obo/NCIT_C4582) (Metastatic Malignant Neoplasm in the Bone Marrow), [NCIT:C8303](http://purl.obolibrary.org/obo/NCIT_C8303) (Adult Acute Myeloid Leukemia with Minimal Differentiation), [NCIT:C7970](http://purl.obolibrary.org/obo/NCIT_C7970) (Childhood Acute Myelomonocytic Leukemia), [NCIT:C7972](http://purl.obolibrary.org/obo/NCIT_C7972) (Childhood Acute Megakaryoblastic Leukemia), [NCIT:C9233](http://purl.obolibrary.org/obo/NCIT_C9233) (Juvenile Myelomonocytic Leukemia), [NCIT:C7175](http://purl.obolibrary.org/obo/NCIT_C7175) (Acute Myeloid Leukemia with Recurrent Genetic Abnormalities), [NCIT:C42779](http://purl.obolibrary.org/obo/NCIT_C42779) (Acute Myelomonocytic Leukemia without Abnormal Eosinophils), [NCIT:C9110](http://purl.obolibrary.org/obo/NCIT_C9110) (Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C8263](http://purl.obolibrary.org/obo/NCIT_C8263) (Adult Acute Monocytic Leukemia), [NCIT:C25765](http://purl.obolibrary.org/obo/NCIT_C25765) (Secondary Acute Myeloid Leukemia), [NCIT:C68744](http://purl.obolibrary.org/obo/NCIT_C68744) (Childhood Myelodysplastic Syndrome), [NCIT:C82591](http://purl.obolibrary.org/obo/NCIT_C82591) (Myelodysplastic Syndrome with Single Lineage Dysplasia), [NCIT:C82593](http://purl.obolibrary.org/obo/NCIT_C82593) (Refractory Neutropenia), [NCIT:C82594](http://purl.obolibrary.org/obo/NCIT_C82594) (Refractory Thrombocytopenia), [NCIT:C82595](http://purl.obolibrary.org/obo/NCIT_C82595) (Myelodysplastic Syndrome with Excess Blasts and Fibrosis), [NCIT:C82596](http://purl.obolibrary.org/obo/NCIT_C82596) (Refractory Cytopenia of Childhood), [NCIT:C80693](http://purl.obolibrary.org/obo/NCIT_C80693) (Bone Marrow Failure), [NCIT:C129786](http://purl.obolibrary.org/obo/NCIT_C129786) (Acute Myeloid Leukemia with Mutated RUNX1), [NCIT:C129785](http://purl.obolibrary.org/obo/NCIT_C129785) (Acute Myeloid Leukemia with BCR-ABL1), [NCIT:C130035](http://purl.obolibrary.org/obo/NCIT_C130035) (Chronic Myelomonocytic Leukemia-0), [NCIT:C4036](http://purl.obolibrary.org/obo/NCIT_C4036) (Myelodysplastic Syndrome with Ring Sideroblasts), [NCIT:C7303](http://purl.obolibrary.org/obo/NCIT_C7303) (Splenic Manifestation of Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C4037](http://purl.obolibrary.org/obo/NCIT_C4037) (Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome), [NCIT:C130037](http://purl.obolibrary.org/obo/NCIT_C130037) (Myelodysplastic Syndrome with Ring Sideroblasts and Single Lineage Dysplasia), [NCIT:C7940](http://purl.obolibrary.org/obo/NCIT_C7940) (Childhood Acute Monoblastic and Monocytic Leukemia), [NCIT:C3182](http://purl.obolibrary.org/obo/NCIT_C3182) (Acute Promyelocytic Leukemia with PML-RARA), [NCIT:C115153](http://purl.obolibrary.org/obo/NCIT_C115153) (Adult Myelodysplastic Syndrome), [NCIT:C9288](http://purl.obolibrary.org/obo/NCIT_C9288) (Acute Myeloid Leukemia with t(8;21); (q22; q22.1); RUNX1-RUNX1T1), [NCIT:C9289](http://purl.obolibrary.org/obo/NCIT_C9289) (Acute Myeloid Leukemia with Multilineage Dysplasia), [NCIT:C41238](http://purl.obolibrary.org/obo/NCIT_C41238) (Primary Myelofibrosis, Overt Fibrotic Stage), [NCIT:C41237](http://purl.obolibrary.org/obo/NCIT_C41237) (Primary Myelofibrosis, Prefibrotic/Early Stage), [NCIT:C9287](http://purl.obolibrary.org/obo/NCIT_C9287) (Acute Myeloid Leukemia with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11), [NCIT:C41233](http://purl.obolibrary.org/obo/NCIT_C41233) (Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase), [NCIT:C41232](http://purl.obolibrary.org/obo/NCIT_C41232) (Polycythemia Vera, Polycythemic Phase), [NCIT:C7319](http://purl.obolibrary.org/obo/NCIT_C7319) (Adult Acute Monoblastic and Monocytic Leukemia), [NCIT:C82616](http://purl.obolibrary.org/obo/NCIT_C82616) (Myelodysplastic/Myeloproliferative Neoplasm with Ring Sideroblasts and Thrombocytosis), [NCIT:C6867](http://purl.obolibrary.org/obo/NCIT_C6867) (Myelodysplastic Syndrome with Isolated del(5q)), [NCIT:C7318](http://purl.obolibrary.org/obo/NCIT_C7318) (Acute Monoblastic and Monocytic Leukemia), [NCIT:C8923](http://purl.obolibrary.org/obo/NCIT_C8923) (Acute Erythroid Leukemia), [NCIT:C8648](http://purl.obolibrary.org/obo/NCIT_C8648) (Myelodysplastic Syndrome, Unclassifiable), [NCIT:C27726](http://purl.obolibrary.org/obo/NCIT_C27726) (Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia), [NCIT:C62505](http://purl.obolibrary.org/obo/NCIT_C62505) (Fanconi Anemia), [NCIT:C4563](http://purl.obolibrary.org/obo/NCIT_C4563) (Chronic Eosinophilic Leukemia, Not Otherwise Specified), [NCIT:C27722](http://purl.obolibrary.org/obo/NCIT_C27722) (Therapy-Related Myelodysplastic Syndrome), [NCIT:C3519](http://purl.obolibrary.org/obo/NCIT_C3519) (Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative), [NCIT:C35501](http://purl.obolibrary.org/obo/NCIT_C35501) (Malignant Bone Marrow Neoplasm), [NCIT:C2872](http://purl.obolibrary.org/obo/NCIT_C2872) (Refractory Anemia), [NCIT:C27753](http://purl.obolibrary.org/obo/NCIT_C27753) (Acute Myeloid Leukemia Not Otherwise Specified), [NCIT:C27350](http://purl.obolibrary.org/obo/NCIT_C27350) (Myeloproliferative Neoplasm, Unclassifiable), [NCIT:C7882](http://purl.obolibrary.org/obo/NCIT_C7882) (Recurrent Adult Acute Myeloid Leukemia), [NCIT:C7643](http://purl.obolibrary.org/obo/NCIT_C7643) (Alkylating Agent-Related Myelodysplastic Syndrome), [NCIT:C27912](http://purl.obolibrary.org/obo/NCIT_C27912) (Therapy-Related Myeloid Neoplasm), [NCIT:C7885](http://purl.obolibrary.org/obo/NCIT_C7885) (Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C27913](http://purl.obolibrary.org/obo/NCIT_C27913) (Alkylating Agent-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome), [NCIT:C7642](http://purl.obolibrary.org/obo/NCIT_C7642) (Epipodophyllotoxin-Related Myelodysplastic Syndrome), [NCIT:C27755](http://purl.obolibrary.org/obo/NCIT_C27755) (Topoisomerase II Inhibitor-Related Acute Myeloid Leukemia), [NCIT:C8574](http://purl.obolibrary.org/obo/NCIT_C8574) (Myelodysplastic Syndrome with Multilineage Dysplasia), [NCIT:C27754](http://purl.obolibrary.org/obo/NCIT_C27754) (Alkylating Agent-Related Acute Myeloid Leukemia), [NCIT:C3164](http://purl.obolibrary.org/obo/NCIT_C3164) (Acute Basophilic Leukemia), [NCIT:C27757](http://purl.obolibrary.org/obo/NCIT_C27757) (Microgranular Acute Promyelocytic Leukemia), [NCIT:C27756](http://purl.obolibrary.org/obo/NCIT_C27756) (Typical Acute Promyelocytic Leukemia), [NCIT:C9153](http://purl.obolibrary.org/obo/NCIT_C9153) (Adult Acute Erythroid Leukemia), [NCIT:C8460](http://purl.obolibrary.org/obo/NCIT_C8460) (Acute Myeloid Leukemia with Minimal Differentiation), [NCIT:C35370](http://purl.obolibrary.org/obo/NCIT_C35370) (Bone Marrow Neoplasm), [NCIT:C36062](http://purl.obolibrary.org/obo/NCIT_C36062) (Chronic Myelomonocytic Leukemia-2), [NCIT:C132101](http://purl.obolibrary.org/obo/NCIT_C132101) (Acute Myeloid Leukemia with t(10;11)(p12;q23); MLL-MLLT10), [NCIT:C3179](http://purl.obolibrary.org/obo/NCIT_C3179) (Chronic Neutrophilic Leukemia), [NCIT:C3178](http://purl.obolibrary.org/obo/NCIT_C3178) (Chronic Myelomonocytic Leukemia), [NCIT:C3336](http://purl.obolibrary.org/obo/NCIT_C3336) (Polycythemia Vera), [NCIT:C122716](http://purl.obolibrary.org/obo/NCIT_C122716) (Acute Myeloid Leukemia with inv(3) (q21.3;q26.2); GATA2, MECOM), [NCIT:C3173](http://purl.obolibrary.org/obo/NCIT_C3173) (Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C3172](http://purl.obolibrary.org/obo/NCIT_C3172) (Myeloid Leukemia), [NCIT:C82433](http://purl.obolibrary.org/obo/NCIT_C82433) (Acute Myeloid Leukemia with Mutated CEBPA), [NCIT:C122717](http://purl.obolibrary.org/obo/NCIT_C122717) (Acute Myeloid Leukemia with t(3;3) (q21.3;q26.2); GATA2, MECOM), [NCIT:C3171](http://purl.obolibrary.org/obo/NCIT_C3171) (Acute Myeloid Leukemia), [NCIT:C9158](http://purl.obolibrary.org/obo/NCIT_C9158) (Childhood Acute Myeloid Leukemia without Maturation), [NCIT:C3170](http://purl.obolibrary.org/obo/NCIT_C3170) (Acute Megakaryoblastic Leukemia), [NCIT:C5630](http://purl.obolibrary.org/obo/NCIT_C5630) (Aleukemic Monocytic Leukemia Cutis), [NCIT:C9156](http://purl.obolibrary.org/obo/NCIT_C9156) (Adult Acute Monoblastic Leukemia), [NCIT:C36061](http://purl.obolibrary.org/obo/NCIT_C36061) (Chronic Myelomonocytic Leukemia-1), [NCIT:C3177](http://purl.obolibrary.org/obo/NCIT_C3177) (Philadelphia-Positive Myelogenous Leukemia), [NCIT:C36060](http://purl.obolibrary.org/obo/NCIT_C36060) (Chronic Myelomonocytic Leukemia with Eosinophilia), [NCIT:C3176](http://purl.obolibrary.org/obo/NCIT_C3176) (Philadelphia-Negative Myelogenous Leukemia), [NCIT:C9154](http://purl.obolibrary.org/obo/NCIT_C9154) (Adult Acute Myeloid Leukemia), [NCIT:C3175](http://purl.obolibrary.org/obo/NCIT_C3175) (Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C9155](http://purl.obolibrary.org/obo/NCIT_C9155) (Adult Acute Promyelocytic Leukemia with PML-RARA), [NCIT:C3174](http://purl.obolibrary.org/obo/NCIT_C3174) (Chronic Myelogenous Leukemia, BCR-ABL1 Positive), [NCIT:C9163](http://purl.obolibrary.org/obo/NCIT_C9163) (Childhood Acute Monocytic Leukemia), [NCIT:C9164](http://purl.obolibrary.org/obo/NCIT_C9164) (Childhood Acute Erythroid Leukemia), [NCIT:C68700](http://purl.obolibrary.org/obo/NCIT_C68700) (Adult Acute Myeloid Leukemia with Recurrent Genetic Abnormalities), [NCIT:C9162](http://purl.obolibrary.org/obo/NCIT_C9162) (Childhood Acute Monoblastic Leukemia), [NCIT:C36058](http://purl.obolibrary.org/obo/NCIT_C36058) (Acute Myeloid Leukemia with t(11;17)(q13;q21)), [NCIT:C9160](http://purl.obolibrary.org/obo/NCIT_C9160) (Childhood Acute Myeloid Leukemia), [NCIT:C36057](http://purl.obolibrary.org/obo/NCIT_C36057) (Acute Myeloid Leukemia with t(5;17)(q35;q21)), [NCIT:C82397](http://purl.obolibrary.org/obo/NCIT_C82397) (Therapy-Related Myelodysplastic/Myeloproliferative Neoplasm), [NCIT:C82430](http://purl.obolibrary.org/obo/NCIT_C82430) (Acute Myeloid Leukemia with Gene Mutations), [NCIT:C36056](http://purl.obolibrary.org/obo/NCIT_C36056) (Acute Myeloid Leukemia with t(11;17)(q23;q21)), [NCIT:C82431](http://purl.obolibrary.org/obo/NCIT_C82431) (Acute Myeloid Leukemia with Mutated NPM1), [NCIT:C36055](http://purl.obolibrary.org/obo/NCIT_C36055) (Acute Myeloid Leukemia with a Variant RARA Translocation), [NCIT:C34433](http://purl.obolibrary.org/obo/NCIT_C34433) (Bone Marrow Disorder), 

**Class expressions from DL-Learner:**

- [NCIT:C34433](http://purl.obolibrary.org/obo/NCIT_C34433) (Bone Marrow Disorder) 99.69%
- [NCIT:C35370](http://purl.obolibrary.org/obo/NCIT_C35370) (Bone Marrow Neoplasm) 98.12%
- [NCIT:C35501](http://purl.obolibrary.org/obo/NCIT_C35501) (Malignant Bone Marrow Neoplasm) 97.81%
- [NCIT:C35501](http://purl.obolibrary.org/obo/NCIT_C35501) (Malignant Bone Marrow Neoplasm) and [NCIT:C9290](http://purl.obolibrary.org/obo/NCIT_C9290) (Myeloid Neoplasm) 97.19%
- [NCIT:C35370](http://purl.obolibrary.org/obo/NCIT_C35370) (Bone Marrow Neoplasm) and [NCIT:C9290](http://purl.obolibrary.org/obo/NCIT_C9290) (Myeloid Neoplasm) 97.19%
- [NCIT:C34433](http://purl.obolibrary.org/obo/NCIT_C34433) (Bone Marrow Disorder) and [NCIT:C9290](http://purl.obolibrary.org/obo/NCIT_C9290) (Myeloid Neoplasm) 97.19%
- [NCIT:C9290](http://purl.obolibrary.org/obo/NCIT_C9290) (Myeloid Neoplasm) 93.11%
- [NCIT:C3161](http://purl.obolibrary.org/obo/NCIT_C3161) (Leukemia) and [NCIT:C35501](http://purl.obolibrary.org/obo/NCIT_C35501) (Malignant Bone Marrow Neoplasm) and [NCIT:C9290](http://purl.obolibrary.org/obo/NCIT_C9290) (Myeloid Neoplasm) 82.19%
- [NCIT:C3161](http://purl.obolibrary.org/obo/NCIT_C3161) (Leukemia) and [NCIT:C35370](http://purl.obolibrary.org/obo/NCIT_C35370) (Bone Marrow Neoplasm) and [NCIT:C9290](http://purl.obolibrary.org/obo/NCIT_C9290) (Myeloid Neoplasm) 82.19%
- [NCIT:C3161](http://purl.obolibrary.org/obo/NCIT_C3161) (Leukemia) and [NCIT:C34433](http://purl.obolibrary.org/obo/NCIT_C34433) (Bone Marrow Disorder) and [NCIT:C9290](http://purl.obolibrary.org/obo/NCIT_C9290) (Myeloid Neoplasm) 82.19%
- [NCIT:C3161](http://purl.obolibrary.org/obo/NCIT_C3161) (Leukemia) and [NCIT:C9290](http://purl.obolibrary.org/obo/NCIT_C9290) (Myeloid Neoplasm) 81.95%
- [NCIT:C3161](http://purl.obolibrary.org/obo/NCIT_C3161) (Leukemia) and [NCIT:C9290](http://purl.obolibrary.org/obo/NCIT_C9290) (Myeloid Neoplasm) and (not ([CL:0009000](http://purl.obolibrary.org/obo/CL_0009000) (sensory neuron of spinal nerve))) 81.95%
- [NCIT:C3161](http://purl.obolibrary.org/obo/NCIT_C3161) (Leukemia) and [NCIT:C9290](http://purl.obolibrary.org/obo/NCIT_C9290) (Myeloid Neoplasm) and (not ([CL:0007010](http://purl.obolibrary.org/obo/CL_0007010) (preosteoblast))) 81.95%
- [NCIT:C3161](http://purl.obolibrary.org/obo/NCIT_C3161) (Leukemia) and [NCIT:C9290](http://purl.obolibrary.org/obo/NCIT_C9290) (Myeloid Neoplasm) and (not ([CL:0007009](http://purl.obolibrary.org/obo/CL_0007009) (prechondroblast))) 81.95%
- [NCIT:C3161](http://purl.obolibrary.org/obo/NCIT_C3161) (Leukemia) and [NCIT:C9290](http://purl.obolibrary.org/obo/NCIT_C9290) (Myeloid Neoplasm) and (not ([CL:0007004](http://purl.obolibrary.org/obo/CL_0007004) (premigratory neural crest cell))) 81.95%


